Reversible Cognitive Frailty, Dementia, and All-Cause Mortality

Presentazione sul tema: "Reversible Cognitive Frailty, Dementia, and All-Cause Mortality"— Transcript della presentazione:

1 Reversible Cognitive Frailty, Dementia, and All-Cause Mortality
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging  Vincenzo Solfrizzi, MD, PhD, Emanuele Scafato, MD, Davide Seripa, PhD, Madia Lozupone, MD, Bruno P. Imbimbo, PhD, Angela D'Amato, MD, Rosanna Tortelli, MD, Andrea Schilardi, MD, Lucia Galluzzo, MD, Claudia Gandin, MD, Marzia Baldereschi, MD, Antonio Di Carlo, MD, Domenico Inzitari, MD, Antonio Daniele, MD, PhD, Carlo Sabbà, MD, Giancarlo Logroscino, MD, PhD, Francesco Panza, MD, PhD Emanuele Scafato, MD, Gino Farchi, MSc, Lucia Galluzzo, MA, Claudia Gandin, MD, Antonio Capurso, MD, Francesco Panza, MD, PhD, Vincenzo Solfrizzi, MD, PhD, Vito Lepore, MD, Paolo Livrea, MD, Luciano Motta, MD, Giuseppe Carnazzo, MD, Massimo Motta, MD, Prospera Bentivegna, MD, Salvatore Bonaiuto, MD, Guido Cruciani, MD, Demetrio Postacchini, MD, Domenico Inzitari, MD, Luigi Amaducci, MD, Antonio Di Carlo, MD, Marzia Baldereschi, MD, Carlo Gandolfo, MD, Massimo Conti, MD, Nicola Canal, MD, Massimo Franceschi, MD, Guglielmo Scarlato, MD, Livia Candelise, MD, Elio Scapini, MD, Franco Rengo, MD, Pasquale Abete, MD, Francesco Cacciatore, MD, Giuliano Enzi, MD, Leontino Battistin, MD, Giuseppe Sergi, MD, Gaetano Crepaldi, MD, Stefania Maggi, MD, Nadia Minicuci, MD, Marianna Noale, MD, Francesco Grigoletto, ScD, Egle Perissinotto, ScD, Pierugo Carbonin, MD Vincenzo Solfrizzi, MD, PhD, Emanuele Scafato, MD, Davide Seripa, PhD, Madia Lozupone, MD, Bruno P. Imbimbo, PhD, Angela D'Amato, MD, Rosanna Tortelli, MD, Andrea Schilardi, MD, Lucia Galluzzo, MD, Claudia Gandin, MD, Marzia Baldereschi, MD, Antonio Di Carlo, MD, Domenico Inzitari, MD, Antonio Daniele, MD, PhD, Carlo Sabbà, MD, Giancarlo Logroscino, MD, PhD, Francesco Panza, MD, PhD Emanuele Scafato, MD, Gino Farchi, MSc, Lucia Galluzzo, MA, Claudia Gandin, MD, Antonio Capurso, MD, Francesco Panza, MD, PhD, Vincenzo Solfrizzi, MD, PhD, Vito Lepore, MD, Paolo Livrea, MD, Luciano Motta, MD, Giuseppe Carnazzo, MD, Massimo Motta, MD, Prospera Bentivegna, MD, Salvatore Bonaiuto, MD, Guido Cruciani, MD, Demetrio Postacchini, MD, Domenico Inzitari, MD, Luigi Amaducci, MD, Antonio Di Carlo, MD, Marzia Baldereschi, MD, Carlo Gandolfo, MD, Massimo Conti, MD, Nicola Canal, MD, Massimo Franceschi, MD, Guglielmo Scarlato, MD, Livia Candelise, MD, Elio Scapini, MD, Franco Rengo, MD, Pasquale Abete, MD, Francesco Cacciatore, MD, Giuliano Enzi, MD, Leontino Battistin, MD, Giuseppe Sergi, MD, Gaetano Crepaldi, MD, Stefania Maggi, MD, Nadia Minicuci, MD, Marianna Noale, MD, Francesco Grigoletto, ScD, Egle Perissinotto, ScD, Pierugo Carbonin, MD  Journal of the American Medical Directors Association  Volume 18, Issue 1, Pages 89.e1-89.e8 (January 2017) DOI: /j.jamda Copyright © 2016 AMDA – The Society for Post-Acute and Long-Term Care Medicine Terms and Conditions

2 Fig. 1 Attrition of the study population at the different phases of the survey for reversible cognitive frailty (rCF) diagnosed with the modified criteria of the IANA/IAGG consensus group, operationalizing the cognitive impairment of rCF as pre-MCI SCD, as recently formulated by the SCD-I Working Group. The Italian Longitudinal Study on Aging, first prevalence survey, 1992–1993. p-yrs, person-years. Journal of the American Medical Directors Association  , 89.e1-89.e8DOI: ( /j.jamda ) Copyright © 2016 AMDA – The Society for Post-Acute and Long-Term Care Medicine Terms and Conditions